St. Anna CCRI hosts 2026 FOSTER Meeting Our institute hosted this year’s meeting of the FOSTER consortium, which stands for Fight Osteosarcoma Through European Research. FOSTER brings together clinicians, researchers and patient representatives to improve diagnostics and therapeutics for patients with osteosarcoma. In Simple Terms– Osteosarcoma is the most common type of bone cancer in […]
St. Anna CCRI hosts 2026 FOSTER Meeting Read More »
Less Chemotherapy, Better Outcomes: Immunotherapy Advances Treatment for High-Risk Childhood Leukemia (Vienna, 17.09.2026) – Treating childhood leukemia often requires intensive chemotherapy, which can severely weaken the immune system and increase the risk of life-threatening infections. An international clinical study involving the Clinical Trials Unit led by Andishe Attarbaschi at St. Anna Children’s Cancer Research Institute (St.
Replicating Cancer’s First Steps – Advanced lab models show how childhood cancer begins As part of Childhood Cancer Awareness Month, researchers at St. Anna CCRI share insights into their current research projects. Here, Polina Kameneva explains that childhood cancers often begin in the womb, making them hard to study and detect in time. Her team
Replicating Cancer’s First Steps – Advanced lab models show how childhood cancer begins Read More »
Darwin explains Cancer – How evolution shapes cancer progression and adaptation As part of Childhood Cancer Awareness Month, researchers at St. Anna CCRI share insights into their current research projects. Here, George Cresswell explains how Charles Darwin’s Theory of Evolution applies to how cancer grows and adapts to resist treatments and evade the immune system.
Darwin explains Cancer – How evolution shapes cancer progression and resistance Read More »
Childhood Cancer Awareness Month: the fight against childhood cancer in the global spotlight in September New therapies, international research and the direct path from the laboratory to the hospital bed offer hope for children with cancer. (Vienna, September 2026). Every year, around 35,000 children and adolescents across Europe are diagnosed with cancer, approximately 300 to
St. Anna CCRI chosen for transatlantic consortium on spectral flow cytometry A transatlantic consortium of 20 leading centers is investigating how spectral flow cytometry can improve and standardize the detection of minimal residual disease in acute myeloid leukemia. St. Anna Children’s Cancer Research Institute is one of only five participating centers in Europe – and
St. Anna CCRI chosen for transatlantic consortium on spectral flow cytometry Read More »
DOC Fellowship: Investigating the genetic alterations behind profound immunodeficiencies. Rare genetic alterations can derail immune development, causing immunodeficiencies and increasing the risk of childhood cancer. Hena Hadzimujagic, a PhD student in Kaan Boztug’s lab, has been awarded a prestigious DOC Fellowship by the Austrian Academy of Sciences to investigate the molecular mechanisms behind one of
When gene regulation goes wrong: uncovering the origins of leukemia B cell development is a carefully controlled process. Genes must be switched on and off at the right time and in the right amount for healthy immune cells to form. When this precise sequence of events is altered, leukemia can develop instead. In a new
When gene regulation goes wrong: uncovering the origins of leukemia Read More »
Protein complex formed by ARID5B and its binding partners.
Mechanism of leukemia predisposition unraveled Read More »
Three research grants to strengthen precision medicine for pediatric cancer patients The Vienna Science and Technology Fund (WWTF) has funded three research projects on pediatric cancer in the same funding round—all of them including researchers at St. Anna CCRI. The projects, designed in collaboration with scientists at other Viennese and German institutions, aim to improve
Three research grants to strengthen precision medicine for pediatric cancer patients Read More »
Florian Halbritter awarded Johann Wilhelm Ritter von Mannagetta Prize for Medicine A computational scientist turned cancer researcher, Florian Halbritter is uncovering how developmental errors drive childhood cancer—work that has now earned him the Johann Wilhelm Ritter von Mannagetta Prize for Medicine from the Austrian Academy of Sciences (ÖAW). The award recognizes scientists under 45 working
Florian Halbritter awarded Johann Wilhelm Ritter von Mannagetta Prize for Medicine Read More »
A SAGA of instability: Without scaffold, a key driver of childhood leukemia falls apart (Vienna, 20.04.2026) – Researchers in the Seruggia group at St. Anna Children’s Cancer Research Institute (St. Anna CCRI) and the CeMM Research Center for Molecular Medicine have uncovered a new way to tackle acute myeloid leukemia (AML) cells in children: Instead of directly targeting
A SAGA of instability: Without scaffold, a key driver of childhood leukemia falls apart Read More »
Emerging Field Grant supports childhood cancer research As part of the excellent=austria initiative, the Austrian Science Fund (FWF) is promoting innovative research collaborations in Austria through its Emerging Fields programme. Over the next five years, selected consortia will work to develop new, highly innovative research fields. Following a competitive international review process focusing on scientific
Emerging Field Grant supports childhood cancer research Read More »
Researchers decode cancer’s genetic control panel one DNA letter at a time Scientists in Davide Seruggia’s group at St. Anna Children’s Cancer Research Institute (St. Anna CCRI), together with collaborators at the Broad Institute of MIT and Harvard, have developed CRISPR-Millipede, a new CRISPR-based method that allows researchers to study regulatory DNA sequences at single-nucleotide
Researchers decode cancer’s genetic control panel one DNA letter at a time Read More »
Guiding Stem Cells Step by Step: New Tool Improves Models of Pediatric Cancer Development To study the molecular causes of pediatric cancer, scientists need to recreate complex developmental processes in the lab – an effort that often requires a great deal of trial and error. Scientists in the labs of Florian Halbritter and Davide Seruggia
Women in Science Day 2026: Then. Now. Tomorrow. Every researcher’s journey begins with curiosity. A question asked as a child. A fascination with how the world works. Today, these childhood dreams live on in our labs. Our researchers are exploring, questioning, and pushing boundaries. Driven by the same curiosity, now paired with expertise, responsibility and purpose.
Women in Science Day 2026 Read More »
